CN Patent
CN108658831B — 2-氧代-1-吡咯烷衍生物或其盐的制备方法
Assigned to Jiangsu Hansoh Pharmaceutical Group Co Ltd · Expires 2021-11-05 · 5y expired
What this patent protects
本发明公开2‑氧代‑1‑吡咯烷衍生物或其盐的制备方法,具体涉及一种制备式(Ⅰ)所示的2‑氧代‑1‑吡咯烷衍生物的方法,式中的取代基如说明书中所定义。本发明的制备方法简单可行、收率高、适合工业化生产。
USPTO Abstract
本发明公开2‑氧代‑1‑吡咯烷衍生物或其盐的制备方法,具体涉及一种制备式(Ⅰ)所示的2‑氧代‑1‑吡咯烷衍生物的方法,式中的取代基如说明书中所定义。本发明的制备方法简单可行、收率高、适合工业化生产。
Drugs covered by this patent
- Briviact (BRIVARACETAM) · UCB
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.